Daiichi Sankyo
Yenlik Zheteyeva is an experienced professional in the field of clinical safety and epidemiology, currently serving as Senior Director of Clinical Safety and Pharmacovigilance in Oncology at Daiichi Sankyo, Inc. Previously, Yenlik held the position of Senior Director of Clinical Safety and Risk Management for Vaccines and Infectious Diseases at Merck. Yenlik's background includes significant roles at the Centers for Disease Control and Prevention, including Senior Medical Epidemiologist, Epidemic Intelligence Service Officer, and Medical Epidemiologist Program Manager. Additionally, Yenlik worked as a Research Consultant at Abt Associates. Educational qualifications include a Master of Public Health in Epidemiology from Emory University and a Medical Doctor degree in General Medicine from Asfendiyarov Kazakh National Medical University.
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.